Chimerix names new chief commercial officer
This article was originally published in Scrip
Executive Summary
Chimerix, a biopharmaceutical company developing oral antivirals in areas of high unmet need, has appointed Linda M Richardson chief commercial officer. She will be responsible for establishing the company's commercial infrastructure and building its capabilities for the potential launch of lead compound brincidofovir. Prior to joining the Durham, North Carolina-based firm Ms Richardson was vice-president and head of the global lixisenatide franchise at Sanofi.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.